Welcome to CSL’s Open Innovation Submission Portal
CSL is a leading global biotech company that develops and delivers innovative biotherapies that help people with life-threatening medical conditions live full lives. Innovation has been in CSL’s DNA for more than a century. CSL has the full spectrum of strengths from research and clinical development to manufacturing and commercialization across six therapeutic areas of expertise. Their strengths enable them to accurately identify, successfully develop, and dependably deliver innovations for patients.
At CSL they believe that for innovation to be fast tracked, they need to partner with the brightest minds in the sector. They know that partnerships can accelerate innovation and delivery of new life-saving and protective medicines and they collaborate and work with external organizations that have unique technologies, assets and equipment, to address patients’ unmet needs around the globe.
If you have an idea related to new products, new technologies or new advancements relating to CSL’s areas of interest, please feel free to share it via the Submission Form. All submissions will be screened by yet2 and if successful, will be shared with CSL. Initial submissions should not include any confidential information.
Core interests for early stage partnering:
Acute thrombotic conditions (macro- and micro-circulation)
- Biologics for targeted thrombolysis in acute thrombosis (ischemic stroke, pulmonary embolism, high-risk deep vein thrombosis (DVT))
- Novel biologic therapies applicable to a broad spectrum of thrombotic microangiopathies (TMAs; pan-treatment)
Acute hemorrhage control and Patient Blood Management (PBM)
- Novel pro-hemostatic therapies for the “universal” treatment of acute bleeds (Direct Oral Anticoagulants (DOACs) AND anti-platelet agent-associated hemorrhage)
Non-viral in vivo gene therapy
- Next generation non-AAV-based gene therapy for Hemophilia A
- In vivo HSC-targeted gene therapy for sickle cell disease
- Novel therapies to treat iron overload conditions
- Novel approaches for treating iron deficiency anemia including novel formulation approaches (oral iron supplementation)
Click each linked title to submit your solution for each need.
Image by FreePik